Hypoestrogenism
Also known as: Estrogen Deficiency / Hypoestrogen / Oestrogen deficiency
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01524 | Androstenediol | Androstenediol is an intermediate in testosterone biosynthesis, found in the testis or the adrenal glands. Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted... |
| DB01536 | Androstenedione | A delta-4 C19 steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as... |
| DB00286 | Conjugated estrogens | A mixture of estrogens used in estrogen replacement therapy for menopause and hypoestrogenism, used in the treatment of various malignancies, and used in the treatment of postmenopausal osteoporosis. |
| DB00783 | Estradiol | An estrogenic steroid used to treat vasomotor symptoms of vulvar and vaginal atrophy in menopause, hypoestrogenism, prevention of postmenopausal osteoporosis, treatment of breast cancer, and advanced androgen-dependent carcinoma of the prostate. |
| DB13953 | Estradiol benzoate | An estrogen indicated in combination with progesterone for the treatment of irregular menstruation. |
| DB13954 | Estradiol cypionate | An estradiol prodrug used to treat vasomotor symptoms and hypoestrogenisms from hypogonadism. |
| DB13956 | Estradiol valerate | An estradiol prodrug used to treat some effects of menopause, hypoestrogenism, androgen dependant carcinoma of the prostate, and in combination products for endometriosis and contraception. |
| DB04573 | Estriol | A weak estrogen used to treat vaginal dryness and estrogen deficiency conditions, such as vaginitis and vulvar itching. |
| DB04574 | Estrone sulfate | An estrogen used as monotherapy or in several combination hormone replacement products for managing menopause symptoms and hormone disorders. |
| DB00717 | Norethisterone | A synthetic second-generation progestin used for contraception, prevention of endometrial hyperplasia in hormone replacement therapy, and in the treatment of other hormone-mediated illnesses such as endometriosis. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00783 | Estradiol | 2 | Completed | 1 |
| DB00396 | Progesterone | 2 | Completed | 1 |
| DB06699 | Degarelix | 4 | Recruiting | 1 |
| DB00783 | Estradiol | 4 | Recruiting | 1 |
| DB00644 | Gonadorelin | 4 | Recruiting | 1 |
| DB00396 | Progesterone | 4 | Recruiting | 1 |
| DB09495 | Avobenzone | Not Available | Completed | 1 |
| DB00783 | Estradiol | Not Available | Completed | 1 |
| DB00783 | Estradiol | Not Available | Recruiting | 1 |
| DB11064 | Homosalate | Not Available | Completed | 1 |
| DB11062 | Octisalate | Not Available | Completed | 1 |
| DB09535 | Octocrylene | Not Available | Completed | 1 |
| DB01428 | Oxybenzone | Not Available | Completed | 1 |
| DB00624 | Testosterone | Not Available | Completed | 1 |